| Business Name: |
Gurbuxani Geeta MD |
| Contact Person: |
Geeta Gurbuxani |
| Address: |
475 Prospect Avenue, West Orange, New Jersey 07052 |
| Phone Number: |
(973) 325-2229 |
| Annual Revenue (USD): |
$500.000 to $999.999 |
| Location Type: |
Single Location |
| Employee Number: |
1 to 4 |
| Business Type: |
B2C (Business to Consumer) |
| Business Category: |
Doctors |
| SIC Code: |
8011 |
| NAICS Code: |
6211110 |
| Share This Business: |
|
| Related Businesses: |
Koziol Joseph M MD - West Orange, NJ 07052
Agarwal Smita MD - West Orange, NJ 07052
Ilyas Humza MD - West Orange, NJ 07052
Roseborough Ingrid E MD - West Orange, NJ 07052
Son Chang B MD - West Orange, NJ 07052
Grebenau Mark MD - West Orange, NJ 07052
Pivawer Lisa DO - West Orange, NJ 07052
Horenstein Marcelo MD - West Orange, NJ 07052
Linsenmeyer Todd MD - West Orange, NJ 07052
Heart Center of Oranges - West Orange, NJ 07052
Lee Bryant B MD - West Orange, NJ 07052
Doctoroff Ella DO - West Orange, NJ 07052
Spates Stephen T MD - West Orange, NJ 07052
Higgins Thomas G MD - West Orange, NJ 07052
Kolodin Eric MD - West Orange, NJ 07052
Fieldman Robert MD - West Orange, NJ 07052
Kamelgard Joseph I MD - West Orange, NJ 07052
Sapru Sunil MD - West Orange, NJ 07052
Morrow Todd MD - West Orange, NJ 07052
Nossa Robert MD - West Orange, NJ 07052
|
The company Gurbuxani Geeta MD provides B2C services in the form of Doctors from its single location in New Jersey.
1 to 4 employees work for Gurbuxani Geeta MD, and the business now earns $500.000 to $999.999 per annum.
Gurbuxani Geeta MD was launched in 0 and is classified under SIC code and category 8011 , and NAICS number and grouping 6211110 .
To contact Gurbuxani Geeta MD, please call Geeta Gurbuxani with the phone number (973) 325-2229 or visit its single location at 475 Prospect Avenue in West Orange, New Jersey 07052.
The location of the single location can also be found using the coordinates 40.79066,-74.25507.
Read more details about this business on the webpage or follow the company’s social media accounts, on Twitter and on Facebook.